Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ruutiainen

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1992
[Rehabilitation of a patient with MS disease]J Ruutiainen
Duodecim; Laaketieteellinen Aikakauskirja|August 17, 2002
[MS patients should get beta-interferon therapy early and for a long time]J Ruutiainen
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1986
[Subdural hematoma--an insidious complication of spinal anesthesia]J Ruutiainen, R Marttila
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1995
[Interferon-beta in the treatment of multiple sclerosis]M Panelius, R Salonen, J Ruutiainen
Brain : a Journal of Neurology|February 1, 1997
The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-upP Kujala, R Portin, J Ruutiainen
Journal of the Neurological Sciences|September 15, 1996
Language functions in incipient cognitive decline in multiple sclerosisP Kujala, R Portin, J Ruutiainen
British Medical Journal (Clinical Research Ed.)|March 19, 1983
Toxic effects of interferon administered intrathecallyJ Ruutiainen, M Panelius, K Cantell
Acta Neurologica Scandinavica|May 1, 1996
Memory deficits and early cognitive deterioration in MSP Kujala, R Portin, J Ruutiainen
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1995
Attention related performance in two cognitively different subgroups of patients with multiple sclerosisP Kujala, R Portin, A Revonsuo, et al.
The Journal of Clinical Psychiatry|January 1, 1986
Myelin basic protein antibodies in catatonic schizophreniaR Rimón, A Ahokas, J Ruutiainen, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1992
[Rehabilitation of a patient with MS disease]J Ruutiainen
Duodecim; Laaketieteellinen Aikakauskirja|August 17, 2002
[MS patients should get beta-interferon therapy early and for a long time]J Ruutiainen
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1986
[Subdural hematoma--an insidious complication of spinal anesthesia]J Ruutiainen, R Marttila
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1995
[Interferon-beta in the treatment of multiple sclerosis]M Panelius, R Salonen, J Ruutiainen
Brain : a Journal of Neurology|February 1, 1997
The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-upP Kujala, R Portin, J Ruutiainen
Journal of the Neurological Sciences|September 15, 1996
Language functions in incipient cognitive decline in multiple sclerosisP Kujala, R Portin, J Ruutiainen
British Medical Journal (Clinical Research Ed.)|March 19, 1983
Toxic effects of interferon administered intrathecallyJ Ruutiainen, M Panelius, K Cantell
Acta Neurologica Scandinavica|May 1, 1996
Memory deficits and early cognitive deterioration in MSP Kujala, R Portin, J Ruutiainen
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1995
Attention related performance in two cognitively different subgroups of patients with multiple sclerosisP Kujala, R Portin, A Revonsuo, et al.
The Journal of Clinical Psychiatry|January 1, 1986
Myelin basic protein antibodies in catatonic schizophreniaR Rimón, A Ahokas, J Ruutiainen, et al.
Pageof 3